Literature DB >> 32562589

Predictors of hemodynamic instability in patients with pheochromocytoma and paraganglioma.

Lulu Ma1, Le Shen1, Xiuhua Zhang1, Yuguang Huang1.   

Abstract

BACKGROUND AND OBJECTIVES: Intraoperative hemodynamic instability is common in patients with pheochromocytoma and paraganglioma. The aim of this study was to identify the predictive risk factors of intraoperative hemodynamic instability.
METHODS: A total of 428 patients having elective resection of pheochromocytoma and/or paraganglioma at Peking Union Medical College Hospital between January 2014 and July 2019 were included. The association between preoperative parameters and the incidence of intraoperative hemodynamic instability were evaluated. Binary logistic regression was used to assess the predictive risk factors of hemodynamic instability.
RESULTS: Patients with intraoperative hemodynamic instability were more prone to have elevated levels of norepinephrine and epinephrine. Binary Logistic regression showed the risk factors of hemodynamic instability were tumor size >5.0 cm (odds ratio [OR], 1.889; 95% confidence interval [CI], 1.243-2.870; P = .003) and five-fold increases of urine epinephrine (OR, 2.195; 95% CI, 1.242-3.880; P = .007).
CONCLUSIONS: Intraoperative hemodynamic instability is common despite adequate preoperative medical treatment. Tumor size and high level of urinary epinephrine are tumor-related factors for intraoperative hemodynamic instability. Identifying these factors can help clinicians to manage patients more effectively and improve patients' outcomes.
© 2020 The Authors. Journal of Surgical Oncology published by Wiley Periodicals LLC.

Entities:  

Keywords:  hemodynamic instability; paraganglioma; pheochromocytoma; tumor size; urine catecholamine

Year:  2020        PMID: 32562589     DOI: 10.1002/jso.26079

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

1.  Non-Selective Alpha-Blockers Provide More Stable Intraoperative Hemodynamic Control Compared with Selective Alpha1-Blockers in Patients with Pheochromocytoma and Paraganglioma: A Single-Center Retrospective Cohort Study with a Propensity Score-Matched Analysis from China.

Authors:  Yang Yang; Jie Zhang; Liqun Fang; Xue Jia; Wensheng Zhang
Journal:  Drug Des Devel Ther       Date:  2022-10-17       Impact factor: 4.319

Review 2.  Giant Paraganglioma Complicated With Catecholamine Crisis and Catecholamine Cardiomyopathy: A Case Report and Review of the Literature.

Authors:  Xiangping Ma; Zhen Chen; Peng Xia; Chunmei Zhang; Keqiang Yan; Yidong Fan; Yingli Wang; Yun Ti; Peili Bu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-03       Impact factor: 5.555

3.  Characteristics of Intraoperative Hemodynamic Instability in Postoperatively Diagnosed Pheochromocytoma and Sympathetic Paraganglioma Patients.

Authors:  Jung Hee Kim; Hyung-Chul Lee; Su-Jin Kim; Kyu Eun Lee; Kyeong Cheon Jung
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-24       Impact factor: 5.555

4.  Should We Hesitate to Perform Laparoscopic Adrenalectomy for Pheochromacytomas Larger Than 5 cm in Diameter with No Pre-Operative Suspicious Criteria for Malignancy?

Authors:  Mehmet Cagatay Cicek; Kadir Omur Gunseren; Cagdas Gokhun Ozmerdiven; Hakan Vuruskan; Ismet Yavascaoglu
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2022-06-28

5.  Surgical treatment of large pheochromocytoma (>6 cm): A 10-year single-center experience.

Authors:  Liang Zhang; Danlei Chen; Yingxian Pang; Xiao Guan; Xiaowen Xu; Cikui Wang; Qiao Xiao; Longfei Liu
Journal:  Asian J Urol       Date:  2022-06-20

6.  Anesthesia and Outcome of 33 Surgeries in 24 Multiple Endocrine Neoplasia Type 2A (MEN2A) Patients: A National Rare Disease Center's Experience.

Authors:  Yaohan Li; Di Jin; Le Shen; Yuguang Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-30       Impact factor: 6.055

7.  Risk factors for hemodynamic instability during laparoscopic resection of pheochromocytoma.

Authors:  Yong-Sheng Huang; Lei Yan; Ze-Yan Li; Zhi-Qing Fang; Zhao Liu; Zhong-Hua Xu; Gang-Li Gu
Journal:  BMC Urol       Date:  2022-09-30       Impact factor: 2.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.